Clinical trial
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell…
NCT00338377 · M.D. Anderson Cancer Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00338377 |
|---|---|
| Title | Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma |
| Official title | Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Prometheus Laboratories Industry Key Biologics, LLC National Cancer Institute (NCI) NIH Adelson Medical Research |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Biological, Drug |
| Interventions | Dendritic Cell Immunization, Cyclophosphamide, Fludarabine, T-Cells, Interleukin-2, Mesna, Intrathecal T-Cells, Intrathecal Interleukin-2 |
| Enrollment | 1,230 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 28, 2030 |
| Completion | Feb 28, 2030 |
| First posted | Jun 20, 2006 |
| Last update posted | Oct 8, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: